| Primary |
| Migraine |
63.6% |
| Cluster Headache |
18.2% |
| Depression |
6.1% |
| Headache |
6.1% |
| Migraine Prophylaxis |
3.0% |
| Product Used For Unknown Indication |
3.0% |
|
| Drug Ineffective |
23.3% |
| Periarthritis |
10.0% |
| Drug Eruption |
6.7% |
| Vomiting |
6.7% |
| Altered State Of Consciousness |
3.3% |
| Drug Effect Decreased |
3.3% |
| Hypersensitivity |
3.3% |
| Malaise |
3.3% |
| Maternal Drugs Affecting Foetus |
3.3% |
| Maternal Exposure Timing Unspecified |
3.3% |
| Migraine |
3.3% |
| No Therapeutic Response |
3.3% |
| Off Label Use |
3.3% |
| Product Quality Issue |
3.3% |
| Product Substitution Issue |
3.3% |
| Pruritus |
3.3% |
| Psoriasis |
3.3% |
| Serotonin Syndrome |
3.3% |
| Somnolence |
3.3% |
| Throat Tightness |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
53.1% |
| Drug Use For Unknown Indication |
26.9% |
| Hypertension |
8.9% |
| Migraine |
3.0% |
| Muscle Spasms |
2.8% |
| Multiple Allergies |
0.9% |
| Pain |
0.9% |
| Hypersensitivity |
0.7% |
| Depression |
0.6% |
| Glaucoma |
0.6% |
| Ankylosing Spondylitis |
0.4% |
| Arthritis |
0.4% |
| Headache |
0.4% |
| Acne |
0.2% |
| Migraine Prophylaxis |
0.2% |
| Stress |
0.2% |
|
| Weight Decreased |
34.0% |
| Vestibular Disorder |
20.0% |
| Serotonin Syndrome |
6.0% |
| Cardio-respiratory Arrest |
4.0% |
| Intentional Drug Misuse |
4.0% |
| Respiratory Arrest |
4.0% |
| Vomiting |
4.0% |
| Completed Suicide |
2.0% |
| Death |
2.0% |
| Hepatitis Viral |
2.0% |
| Medication Error |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Pain In Extremity |
2.0% |
| Product Substitution Issue |
2.0% |
| Renal Failure |
2.0% |
| Somnolence |
2.0% |
| Tachycardia |
2.0% |
| Withdrawal Syndrome |
2.0% |
| Wrong Technique In Drug Usage Process |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.1% |
| Migraine |
9.2% |
| Crohn's Disease |
7.1% |
| Product Used For Unknown Indication |
6.7% |
| Pain |
5.0% |
| Prophylaxis |
4.4% |
| Depression |
4.2% |
| Rheumatoid Arthritis |
3.6% |
| Headache |
3.4% |
| Anxiety |
2.9% |
| Premedication |
2.9% |
| Constipation |
2.5% |
| Asthma |
2.3% |
| Hypertension |
2.3% |
| Neoplasm |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Insomnia |
1.9% |
| Migraine Prophylaxis |
1.9% |
| Narcolepsy |
1.7% |
| Nausea |
1.7% |
|
| Vomiting |
20.0% |
| Weight Decreased |
13.3% |
| Pain |
6.7% |
| Somnolence |
6.7% |
| Condition Aggravated |
5.0% |
| Vision Blurred |
5.0% |
| Weight Fluctuation |
5.0% |
| Alopecia |
3.3% |
| Disease Progression |
3.3% |
| Headache |
3.3% |
| Influenza Like Illness |
3.3% |
| Initial Insomnia |
3.3% |
| Left Ventricular Dysfunction |
3.3% |
| Middle Insomnia |
3.3% |
| Oedema Peripheral |
3.3% |
| Rash Papular |
3.3% |
| Tricuspid Valve Incompetence |
3.3% |
| Abnormal Dreams |
1.7% |
| Amnesia |
1.7% |
| Anxiety |
1.7% |
|
| Interacting |
| Ankylosing Spondylitis |
15.4% |
| Depression |
15.4% |
| Drug Use For Unknown Indication |
10.3% |
| Acne |
7.7% |
| Headache |
7.7% |
| Localised Infection |
7.7% |
| Muscle Spasms |
7.7% |
| Pain |
7.7% |
| Migraine |
5.1% |
| Migraine Prophylaxis |
5.1% |
| Tetanus Immunisation |
5.1% |
| Dental Care |
2.6% |
| Prophylaxis |
2.6% |
|
| Withdrawal Syndrome |
50.0% |
| Tachycardia |
25.0% |
| Tremor |
25.0% |
|